Belgium vs Bhutan: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
Bhutan
1
in 2020
Belgium rank
10th
Bhutan rank
8th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Bhutan
How they compare
Bhutan currently reports 1 against 0.6 in Belgium, a difference of 0.4.
That makes Bhutan's figure about 1.7 times Belgium's.
Across all 8 years both countries report, Bhutan has been ahead every year.
Belgium ranks 10th and Bhutan ranks 8th of 52 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0 | 1.48 | 1.48 | Bhutan |
| 2020s | 0.6 | 1 | 0.4 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Bhutan?
- Bhutan, at 1 against 0.6 in Belgium as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Bhutan?
- 0.4, with Bhutan ahead.
- How many years of comparable data are there for Belgium and Bhutan?
- 8 years are reported by both, from 2009 to 2020.
- How do Belgium and Bhutan rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and Bhutan ranks 8th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.